Trial Profile

A Phase 1, Randomized, Double-blind, Parallel and Placebo-controlled Single and Multiple Ascending Dose Trial Investigating Safety, Tolerability and Pharmacokinetics of LIB-01 in Healthy Participants

Status: Completed

Phase of Trial: Phase I

Latest Information Update: 20 Dec 2024

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

17 Dec 2024 According to a Dicot media release, data from this trial have been selected for presentation at the European Society for Sexual Medicine's annual congress.
31 Oct 2024 According to a Dicot media release, In October, in-depth clinical results from the phase 1 study were presented by Dr. Harin Padma-Nathan at the largest U.S. conference in sexual medicine.
05 Apr 2024 According to a Dicot media release, the initial reporting is scheduled for the end of April. An in-depth summary of results for the entire Phase 1 study will be presented later in the second quarter.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com